[HTML][HTML] Biomaterials to enhance stem cell transplantation

BN Kharbikar, P Mohindra, TA Desai - Cell Stem Cell, 2022 - cell.com
The successful transplantation of stem cells has the potential to transform regenerative
medicine approaches and open promising avenues to repair, replace, and regenerate …

[HTML][HTML] Retinitis pigmentosa: novel therapeutic targets and drug development

KY Wu, M Kulbay, D Toameh, AQ Xu, A Kalevar… - Pharmaceutics, 2023 - mdpi.com
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by
progressive degeneration of retinal photoreceptors leading to progressive visual decline. It …

Repeated topical administration of 3 nm cerium oxide nanoparticles reverts disease atrophic phenotype and arrests neovascular degeneration in AMD mouse models

A Badia, A Duarri, A Salas, J Rosell, J Ramis… - ACS …, 2023 - ACS Publications
Increased oxidative stress in the retina and retinal pigment epithelium is implicated in age-
related macular degeneration (AMD). Antioxidant cerium oxide nanoparticles (CeO2NPs) …

Stem cell therapy for retinal degeneration: the evidence to date

A Sharma, BG Jaganathan - Biologics: Targets and Therapy, 2021 - Taylor & Francis
There is a rise in the number of people who have vision loss due to retinal diseases, and
conventional therapies for treating retinal degeneration fail to repair and regenerate the …

[HTML][HTML] Gene-agnostic therapeutic approaches for inherited retinal degenerations

MC John, J Quinn, ML Hu… - Frontiers in Molecular …, 2023 - frontiersin.org
Inherited retinal diseases (IRDs) are associated with mutations in over 250 genes and
represent a major cause of irreversible blindness worldwide. While gene augmentation or …

[HTML][HTML] Stem cell therapy in retinal diseases

A Voisin, A Pénaguin, A Gaillard… - Neural Regeneration …, 2023 - journals.lww.com
Alteration of the outer retina leads to various diseases such as age-related macular
degeneration or retinitis pigmentosa characterized by decreased visual acuity and ultimately …

Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease

MI Móvio, TH de Lima-Vasconcellos… - Seminars in Cell & …, 2023 - Elsevier
Human-induced pluripotent stem cells (hiPSCs) have provided new methods to study
neurodegenerative diseases. In addition to their wide application in neuronal disorders …

[HTML][HTML] Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision

F Karamali, S Behtaj, S Babaei-Abraki… - Journal of translational …, 2022 - Springer
Photoreceptors (PRs), as the most abundant and light-sensing cells of the neuroretina, are
responsible for converting light into electrical signals that can be interpreted by the brain. PR …

Acellularized uvea hydrogel as novel injectable platform for cell‐based delivering treatment of retinal degeneration and optimizing retinal organoids inducible system

G Li, S Liu, W Chen, Z Jiang, Y Luo… - Advanced …, 2022 - Wiley Online Library
Replenishing the retina with retinal pigment epithelial (RPE) cells derived from pluripotent
stem cells (PSCs) has great promise for treating retinal degenerative diseases, but it is …

[HTML][HTML] Efficient correction of Abca4 variants by CRISPR-Cas9 in hiPSCs derived from stargardt disease patients

L Siles, S Ruiz-Nogales, A Navinés-Ferrer… - … Therapy-Nucleic Acids, 2023 - cell.com
Inherited retinal dystrophies comprise a broad group of genetic eye diseases without
effective treatment. Among them, Stargardt disease is the second most prevalent pathology …